What is Scripta Insights?
Scripta Insights operates within the dynamic healthcare technology sector, specializing in pharmacy benefit cost containment. The company provides a comprehensive suite of tools, including an AI-driven Rx Navigation platform, to help stakeholders reduce prescription expenses. By offering unbiased medication recommendations and personalized savings reports, Scripta Insights empowers individuals to make more informed decisions about their healthcare spending. Their commitment extends to improving medication access and affordability, while simultaneously boosting member engagement through various support initiatives, ultimately aiming for better health outcomes and tangible savings.
How much funding has Scripta Insights raised?
Scripta Insights has raised a total of $17M across 1 funding round:
Series B
$17M
Series B (2024): $17M with participation from Eastside Partners, Contour Venture Partners, Aquiline Capital Partners, and Remy Investors & Consultants
Key Investors in Scripta Insights
Eastside Partners
Eastside Partners is a venture capital firm that focuses on growth-stage investments, particularly in SaaS, tech-enabled services, and healthcare. They are known for building relationships with entrepreneurs and providing strategic guidance to enhance company value.
Contour Venture Partners
Contour Venture Partners is a seed-stage venture capital firm based in New York, specializing in innovative software solutions within enterprise SaaS, vertical B2B SaaS, and financial services. They act as business partners, offering advice and support to portfolio companies.
Aquiline Capital Partners
Aquiline Capital Partners is a private investment firm with a focus on businesses across the financial services sector, including financial technology, insurance, investment management, business services, credit, and healthcare.
What's next for Scripta Insights?
The substantial enterprise-level capital infusion positions Scripta Insights for accelerated growth and market expansion. With a recent major strategic investment, the company is poised to further develop its AI capabilities and broaden its service offerings. This backing will likely fuel enhancements to its Rx Navigation platform, enabling more sophisticated cost-saving analyses and personalized member support. Scripta Insights is expected to leverage this financing to strengthen its market presence, forge new partnerships within the healthcare ecosystem, and solidify its position as a leader in pharmacy benefit cost management, driving innovation in medication affordability.
See full Scripta Insights company page
